课题基金 / 基金详情

Novel targets to treat airway fibrosis

Novel targets to treat airway fibrosis
治疗气道纤维化的新靶点
批准号:
nhmrc : 1026880
负责人:
A/Pr Brian Oliver
金额:
$28.18万
依托单位国家:
澳大利亚
项目类别:
Career Development Fellowships
财政年份:
2012
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2012-01-01 至 2015-12-31

项目摘要

项目成果

A/Pr Brian Oliver的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Airway fibrosis or scaring causes significant morbidity in both chronic obstructive pulmonary disease (COPD) and asthma . These diseases affect 10-15% of the population, and cost the health system $1.15 billion per year. Airway fibrosis is not decreased by the current therapeutics used to treat COPD and asthma, and as such there is a pressing need to develop therapeutics to specifically treat airway fibrosis. Dr Brian Oliver has partnered with Pharmaxis to develop new therapeutics to specifically treat fibrosis
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidation of the Aetiology of Airway Remodelling in COPD
  • 批准号:
    nhmrc : 1104704
  • 项目类别:
    Project Grants
  • 资助金额:
    $43.08万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Brian Oliver
  • 依托单位:
Elucidation of the Aetiology of Airway Remodelling in COPD
  • 批准号:
    nhmrc : GNT1104704
  • 项目类别:
    Project Grants
  • 资助金额:
    $62.7万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Brian Oliver
  • 依托单位:
Novel methods to treat airway remodelling
  • 批准号:
    nhmrc : GNT1110368
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $46.37万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Brian Oliver
  • 依托单位:
Novel methods to treat airway remodelling
  • 批准号:
    nhmrc : 1110368
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $31.9万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Brian Oliver
  • 依托单位:
国内基金
海外基金
miR-29a "targets" PPAR δ对心力衰竭的作用及作为潜在标志物的研究
  • 批准号:
    81371895
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2013
  • 负责人:
    臧明玺
  • 依托单位: